High-Risk Localized and Locally Advanced Prostate Cancer

Around 20%–30% of nonmetastatic prostate cancer patients have high-risk localized disease. The best treatment for high-risk localized disease is still unclear, and the reliability of the definition of “high-risk” may need to be validated first. Although recent advances in radiotherapy for prostate c...

Ausführliche Beschreibung

Bibliographische Detailangaben

Format:	Online
Sprache:	Englisch
Veröffentlicht:	MDPI - Multidisciplinary Digital Publishing Institute 2023
Schlagworte:	imaging modality &nbsp oligometastasis radical prostatectomy lymph node dissection brachytherapy hormonal therapy neoadjuvant/adjuvant therapy quality of life local invasion thema EDItEUR::T Technology, Engineering, Agriculture, Industrial processes::TB Technology: general issues thema EDItEUR::T Technology, Engineering, Agriculture, Industrial processes::TC Biochemical engineering::TCB Biotechnology
Online-Zugang:	ONIX_20230808_9783036581682_54
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!